Quellen:
https://ec.europa.eu/health/non_communicable_diseases/rare_diseases_en
Evans W R, Rafi I. Rare diseases in general practice: recognising the zebras among the horses. Br. J. Gen. Pract. 2016;66:550-551, DOI: 10.3399/bjgp16X687625
Engel P A, Bagal S, Broback M, Boice N. Physician and patient perception regarding physician training in rare diseases: The need for stronger educational initiatives for physicians. Journal of Rare Disorders 2013; 1
Blöß S et al. Diagnostic needs for rare diseases and shared prediagnostic phenomena: Results of a German-wide expert Delphi survey. PLoS One 2017;12 (2): art. no. e0172532
Schieppati A et al. Why rare diseases are an important medical and social issue. Lancet 2008;371:2039-2041. DOI: 10.1016/S0140-6736(08)60872-7
https://www.vfa.de/de/arzneimittel-forschung/seltene-erkrankungen/die-entwicklung-von-orphan-drugs
https://www.vfa.de/de/arzneimittel-forschung/datenbanken-zu-arzneimitteln/orphan-drugs-list
Wörmann B. Frühe Nutzenbewertung: Risiken und Nebenwirkungen. Deutsches Ärzteblatt;112 (19), A858-A862
Daniel M G et al. The orphan drug Act: restoring the mission to rare diseases. Am. Journal of clinical oncology. 39 (2):210-213
Glaeske G, Ludwig W-D. Innovationsreport 2017. Auswertungsergebnisse von Routinedaten der Techniker Krankenkasse aus den Jahren 2014 bis 2016. http://www.socium.uni-bremen.de/uploads/ news/2017/170920_innovationsreport_2017_langfassung.pdf [05.11.2018].
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Patzer, KH. Patienten auf Odyssee: Sieben Ärzte bis zur richtigen Diagnose. MMW - Fortschritte der Medizin 163, 12–15 (2021). https://doi.org/10.1007/s15006-021-9596-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15006-021-9596-1